The battle against influenza: The role of neuraminidase inhibitors in children

Canadian Journal of Infectious Diseases

Volumn 11, Issue 6, 2000, Pages 295-298

  Allen, U ^a  

^a Lab Ctr Dis Contr I   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 ACETAMIDO 5 AMINO 3 (1 ETHYLPROPOXY) 1 CYCLOHEXENE 1 CARBOXYLIC ACID; AMANTADINE; OSELTAMIVIR; PERAMIVIR; PROBENECID; RIMANTADINE; SIALIDASE; SIALIDASE INHIBITOR; VIRUS ENZYME; ZANAMIVIR;

CHILD; CHILD HEALTH CARE; CLINICAL TRIAL; DRUG BIOAVAILABILITY; DRUG CONTRAINDICATION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG INDICATION; DRUG INDUCED DISEASE; DRUG SPECIFICITY; DRUG TOLERABILITY; HUMAN; INFLUENZA; NOTE; PREGNANCY;

EID: 0034509387     PISSN: 11802332     EISSN: None     Source Type: Journal    
DOI: 10.1155/2000/189398     Document Type: Note

References (29)

1. Influenza
2. Influenza in Canada - 1998-1999 Season
3. Influenza and the rates of hospitalization for respiratory disease among infants and young children
4. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children
5. Influenza and hospitalizations in children
6. Influenza virus neuraminidase inhibitors
7. Oseltamivir
8. New approaches to influenza chemotherapy. Neuraminidase inhibitors
9. 2-Doexy-2-3-dehydroxialic acids I. Synthesis and properties of 2-deoxy,3 dehydro-N-acylneuraminic acids and their methyl esters
10. Neuraminidase inhibitors for treatment of influenza A and B infections
11. Zanamivir
12. Antiviral drugs (other than antiretrovirals)
13. The pharmacokinetics and safety of the oral neuraminidase inhibitor Ro 64-0796/GS4104 when administered concurrently with cimetidine or probenecid in healthy subjects
14. Zanamivir
15. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza virus infections
16. Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group
17. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza A and B virus infections
18. Zanamivir in the prevention of influenza among healthy adults: A randomized controlled trial
19. Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: A randomized controlled trial
20. Pharmacokinetics and tolerability of a single inhaled dose of zanamivir in children
21. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: A randomized controlled trial. US Oral Neuraminidase Study Group
22. Influenza treatment with oral oseltamivir reduces viral load and antibiotic use related to respiratory complications
23. Oral GS4104 in the treatment of influenza in adults is effective and reduces influenza-related complications and need for antibiotic treatment
24. Pharmacokinetics of the oral neuraminidase inhibitor oseltamivir in pediatric patients
25. Oral oseltamivir is effective and safe in the treatment of children with acute influenza